Delivery Order SPE2DB20D2014-SPE2DB24FB15G
Award Date 2/22/24
Potential Completion Date 2/23/24
Potential Value $4.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through December 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military and...
- This federal contract award, valued at $48,748.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,563,250,472 units of the drug Ondansetron ODT 4 mg tablet, with a performance period through January 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,559,720,792 units of Ondansetron ODT 4 mg tablets. The award, valued at $1,225.78, has a firm fixed-price pricing type and an ultimate completion date of January 26, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company,...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. It is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999. The contract covers the supply of 4,566,719,877 units of the generic drug Ondansetron ODT 4 mg tablets in 30-count packages. This is a firm fixed-price contract with a ceiling value of $2,677.43 and a completion date...
- This federal contract award to Amerisourcebergen Drug Corporation (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) Troop Support Medical. It is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The specific contract award is for the supply of 4,565,468,004 units of...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order issued by the Defense Logistics Agency (DLA) under their Indefinite Delivery Contract (IDC) valued at $999,999,999 through November 2026. The contract provides for a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,245.96 firm fixed-price delivery order is for 4,564,413,840 units of the medication Ondansetron ODT 4 mg tablet. The contract has an ultimate completion date of April 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc. valued at up to $999,999,999.00, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,387.14 firm fixed-price delivery order is for 4,567,105,161 units of the medication Ondansetron ODT 4 mg Tablet 30s, with a performance period through January 31, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This federal contract award, valued at $3,379.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4,560,993,787 units of Ondansetron ODT 4 mg Tablet 30s, a pharmaceutical product. The contract has an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award, valued at $4,557.27, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order against an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...